AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
Log in

ASX:AC8Auscann Group Stock Price, Forecast & News

A$0.17
0.00 (0.00 %)
(As of 05/12/2020)
Add
Compare
Today's Range
A$0.17
Now: A$0.17
A$0.18
50-Day Range N/A
52-Week Range
A$0.14
Now: A$0.17
A$0.53
Volume537,446 shs
Average VolumeN/A
Market Capitalization$53.90 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AusCann Group Holdings Ltd researches, develops, cultivates, produces, and sells clinically validated cannabis medicines to patients in Australia. The company has a strategic partnership with Tasmanian Alkaloids. AusCann Group Holdings Ltd is headquartered in Joondalup, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.02 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 0 9561 8834

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$670,606.00
Cash FlowA$0.08 per share
Book ValueA$0.12 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$53.90 million
Next Earnings DateN/A
OptionableNot Optionable

Receive AC8 News and Ratings via Email

Sign-up to receive the latest news and ratings for AC8 and its competitors with MarketBeat's FREE daily newsletter.

Auscann Group (ASX:AC8) Frequently Asked Questions

Has Auscann Group been receiving favorable news coverage?

Press coverage about AC8 stock has trended extremely negative on Friday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Auscann Group earned a daily sentiment score of -4.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutAuscann Group.

Who are some of Auscann Group's key competitors?

What other stocks do shareholders of Auscann Group own?

Who are Auscann Group's key executives?

Auscann Group's management team includes the following people:
  • Dr. Paul Donald Richard MacLeman MBA, BVSc, Grad Dip Tech, Grad Cert Eng, GAICD, MA, Interim CEO & Exec. Director (Age 53)
  • Mr. Quentin Heath Megson, Chief Operating & Financial Officer and Joint Company Sec. (Age 48)
  • Ms. Susan Patricia Hunter A.C.A., B.Com., BCom, F Fin, ACA, AGIA, FFin, GAIC, Company Sec. (Age 44)
  • Dr. Danial Schecter, Chief Medical Advisor (Age 45)

What is Auscann Group's stock symbol?

Auscann Group trades on the ASX under the ticker symbol "AC8."

What is Auscann Group's stock price today?

One share of AC8 stock can currently be purchased for approximately A$0.17.

How big of a company is Auscann Group?

Auscann Group has a market capitalization of $53.90 million and generates $670,606.00 in revenue each year.

What is Auscann Group's official website?

The official website for Auscann Group is www.auscann.com.au.

How can I contact Auscann Group?

The company can be reached via phone at 61 0 9561 8834.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.